Lixte Biotechnology Holdings, Inc.: Revision history

14 August 2022

• curprev 08:0808:08, 14 August 2022 103.126.60.198 talk 1,230 bytes +11 No edit summary undo

13 August 2022

• curprev 09:1509:15, 13 August 2022 109.180.50.163 talk 1,219 bytes +15 No edit summary undo

30 July 2022

• curprev 00:1800:18, 30 July 2022 >Chris 1,204 bytes +1,204 Created page with "Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinic..."